NCT02944500 Saxenda: Underlying Mechanisms and Clinical Outcomes Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT02930265 Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy Status UNKNOWN Phase NA
NCT02920190 Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat Status WITHDRAWN Phase PHASE4
NCT02918279 Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity Status COMPLETED Phase PHASE3
NCT02909933 Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity Status COMPLETED Phase PHASE4
NCT02889510 Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT02870231 Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity Status COMPLETED Phase PHASE1
NCT02863419 Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT02787551 Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period Status COMPLETED Phase PHASE3
NCT02765399 The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis Status COMPLETED Phase PHASE4
NCT02730377 Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT02721888 Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism Status TERMINATED Phase PHASE4
NCT02717858 A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects. Status COMPLETED Phase PHASE1
NCT02696148 A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years Status COMPLETED Phase PHASE1
NCT02674893 Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes Status TERMINATED Phase PHASE4